Clik here to view.
Patients with Severe Paralysis Use Stentrode Brain-Computer Interface to...
SAN FRANCISCO & NEW YORK CITY & MELBOURNE Synchron, a neurovascular bioelectronics medicine company, today announced publication of a first-in-human study demonstrating successful use of the...
View ArticleClik here to view.
First Patients Treated with the World’s Smallest Heart Pump, the 9Fr Impella ECP
DANVERS, Mass. Abiomed (NASDAQ: ABMD) announces the first two patients have been treated with the Impella ECP expandable percutaneous heart pump. Impella ECP is the smallest heart pump in the world....
View ArticleClik here to view.
Takeda Expands COVID-19 Vaccine Supply in Japan Through Partnership with...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK), announced today that it will import and distribute 50 million doses of Moderna’s COVID-19 vaccine candidate, mRNA-1273,...
View ArticleClik here to view.
武田薬品工業:...
大阪 （ビジネスワイヤ） – 武田薬品工業株式会社（TSE:4502/NYSE:TAK）は、本日、2020年度上期の業績を公表しましたのでお知らせします。 当社代表取締役社長CEOのクリストフ・ウェバーは次のように述べています。...
View ArticleClik here to view.
Takeda FY2020 H1 Results Demonstrate Portfolio Resilience; Confirms Full-Year...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced financial results for the first half of fiscal year 2020 (period ended September 30, 2020). TAKEDA...
View ArticleClik here to view.
Sengenics Launches SEROMAX, an At-Home, Antibody Sample Collection Kit That...
SINGAPORE Sengenics, the Functional Proteomics Company, today announced the launch of SEROMAX, a sample collection kit which only requires a pin-prick amount of blood for quantifying antibodies or...
View ArticleClik here to view.
Ocular Therapeutix™ and AffaMed Therapeutics Announce License Agreement and...
BEDFORD, Mass. Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions...
View ArticleClik here to view.
The McQuade Center for Strategic Research and Development Enters...
PRINCETON, N.J. The McQuade Center for Strategic Research and Development, LLC (MSRD), a member of the global Otsuka family of pharmaceutical companies, announced today that it has entered an...
View ArticleClik here to view.
Clik here to view.
世界最小心臓ポンプの9Fr Impella ECPで初めて患者を治療
米マサチューセッツ州ダンバース （ビジネスワイヤ） — アビオメッド（NASDAQ: ABMD）は、拡張型経皮的心臓ポンプImpella ECPによる治療を2人の患者が初めて受けたことを発表しました。Impella...
View ArticleClik here to view.
DESTINY-Breast05 Head-to-Head Phase 3 Trial of ENHERTU® Versus T-DM1...
TOKYO & MUNICH & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today announced the initiation of DESTINY-Breast05, a global phase 3,...
View ArticleClik here to view.
Nucleix研发的Lung EpiCheck®液体活检，可检出高危吸烟者中85%的早期肺癌，该研究已发表于《欧洲呼吸杂志》。
圣迭戈与雷霍沃特，以色列 Nucleix，以色列一家对疾病进行早期检测从而彻底改变癌症治疗的液体活检公司，今日宣布在《欧洲呼吸杂志》最新论文中，该公司所研发的Lung EpiCheck®检测，可依据吸烟史在肺癌高危个体中检验出85%的早期肺癌。该论文已发表在《欧洲呼吸杂志》(ERJ)印刷版之前的在线版中，标题为“Lung...
View ArticleClik here to view.
Masimo宣布Radius VSM™在部分市场上市
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天宣布，可穿戴、无线缆生命体征监护仪Radius VSM™已获得CE认证，正在部分欧洲市场上市。多功能、可扩展Radius VSM能监测多种生理指标，包括连续SET®脉搏血氧饱和度、无创血压、体温、呼吸频率和心电图(ECG)。Radius...
View ArticleClik here to view.
マシモがRadius VSM™の限定市場リリースを発表
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ：MASI）は本日、ウエアラブルでテザーレスのバイタルサインモニターであるRadius VSM™がCEマークを取得し、欧州の限定市場で発売されることを発表しました。多用途性と拡張性のあるRadius...
View ArticleClik here to view.
联拓生物宣布获得Infigratinib在中国大陆开展治疗针对具有FGFR2基因融合的局部晚期或转移性不可切除胆管癌患者的3期PROOF临床试验批件
上海和普林斯顿（新泽西州） (美国商业资讯) — 联拓生物，一家专注于为中国和亚洲主要市场的患者带来颠覆性药物的生物制药公司，今日宣布已获得中国国家药品监督管理局（NMPA）药品审评中心（CDE）关于Infigratinib的3期PROOF临床试验批件。Infigratinib是一种潜在的用于治疗伴有FGFR2基因融合的局部晚期或转移性不可切除胆管癌患者的一线治疗方式。...
View ArticleClik here to view.
武田2020财年上半年业绩展示出其产品组合的韧性；确认全年管理层指引，上调对自由现金流、列报营业利润和列报每股盈利的预测
日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited) (TSE:4502/NYSE:TAK)（“武田”）今天公布其2020财年上半年（截至2020年9月30日期间）的财务业绩。 武田总裁兼首席执行官CHRISTOPHE WEBER评论道：...
View ArticleClik here to view.
Modalis Therapeutics Reports Third Quarter 2020 Financial Results and...
TOKYO & CAMBRIDGE, Mass. Modalis Therapeutics Corporation (Modalis) (TOKYO: 4883), a leading company developing innovative products for the treatment of rare genetic diseases utilizing its...
View ArticleClik here to view.
Takeda Oncology Demonstrates Leadership in Hematologic Cancers at 62nd...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it will present 22 company-sponsored abstracts at the 62nd American...
View ArticleClik here to view.
BeiGene Reports Third Quarter 2020 Financial Results
CAMBRIDGE, Mass. & BEIJING BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today...
View ArticleClik here to view.
SpeeDx与Nepean医院合作，实现呼吸道病毒宿主生物标记物检测的商业化
悉尼 (美国商业资讯)–SpeeDx Pty. Ltd.是创新分子诊断解决方案的开发者，已与Nepean蓝山地区卫生区(NBMLHD) Nepean医院的研究人员合作，达成一项排他性协议，将呼吸道病毒性疾病宿主基因表达生物标记物检测商业化。由NBMLHD的Anthony Maclean博士、Benjamin...
View Article